Free shipping on orders over $150
Selank 10mg research vial

peptides

Selank 10mg

Selank is a synthetic analog of tuftsin studied for anxiolytic effects without sedation, GABAergic modulation, and immunomodulatory action — typically administered intranasally.

Research-observed benefits

  • Calm focus
  • Anxiolytic profile
  • Immune modulation
  • Mood support

Findings reported in in-vitro / preclinical research literature. Not therapeutic claims.

CAS Number

Purity

99%+

Molecular Formula

Stock

220 units

Order type

Purchase option

Quantity

1

Total

$40

For in-vitro research only. Not for human consumption, diagnostic, or therapeutic use. Storage at -20°C recommended for lyophilized peptides.

Selank 10mg — Full Research Breakdown

Tailored information for researchers. All content is for in-vitro / preclinical research context only — not medical advice.

Mechanism of Action

Synthetic heptapeptide analog of tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). Modulates GABAergic and serotonergic tone, upregulates BDNF expression, and shifts cytokine balance (IL-6, IFN, IL-2) toward an immunomodulatory profile — without sedation, dependence, or withdrawal observed with benzodiazepine-class agents.

How It Helps

Studied for anxiolytic activity that preserves alertness, mood stabilization, attention under stress, and immune balance during prolonged psychological or physical load.

Half-Life

Short plasma half-life (minutes); downstream neurochemical effects persist for hours per dose.

Onset of Effects

Calming effect commonly reported within 20–60 minutes intranasally; cumulative mood effects build over 1–3 weeks.

Storage

Lyophilized: 2–8°C short-term, –20°C long-term. Reconstituted: refrigerate 2–8°C, use within 28 days.

Stacks Well With

  • Semax (cognitive + anxiolytic synergy)
  • BPC-157 (systemic stress recovery)
  • NAD+ (energy support)

Research-Observed Side Effects

  • Mild nasal dryness or irritation
  • Occasional transient drowsiness at higher doses
  • Rarely: mild GI upset

Translational Cautions

  • Concurrent benzodiazepine or sedative protocols without specialist oversight
  • Active pregnancy in human translational models

Research Highlights

  • Russian clinical literature: anxiolytic efficacy comparable to medazepam without sedation, ataxia, or withdrawal.
  • Documented modulation of serum BDNF and balance of IL-6 / IFN cytokines.
  • Preclinical models: attention and adaptive behavior preserved under chronic stress.

Researcher FAQ